EUVIMEDEUVIMED entdecken
Open Access

CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate

Keisuke Sawada, Takumi Takahashi, Yuki Fukumura, Hiroko Onagi, Karin Ashizawa, Takahisa Yamashita, Wataru Yamamoto, Natsuko Takayanagi, Akiko Adachi, Makoto Kashimura, Takayuki Tabayashi, Jun-Ichi Tamaru und 2 weitere

Journal of Clinical and Experimental Hematopathology · 2026 · 66 (1) · 27-36

DOI: 10.3960/jslrt.25087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Keisuke Sawada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Methotrexate, Lymphoma, Large B-Cell, Diffuse, Arthritis, Rheumatoid, Biomarkers, Tumor. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateLymphoma, Large B-Cell, DiffuseArthritis, RheumatoidBiomarkers, TumorAntigens, CDMembrane GlycoproteinsImmunoglobulinsHumansFemalePrognosisMaleCD83 AntigenMiddle AgedAged

Stichwörter der Autor:innen

CD83diffuse large B-cell lymphomaimmune deficiency/dysregulationmethotrexaterheumatoid arthritis

Substanzen

MethotrexateBiomarkers, TumorAntigens, CDCD83 AntigenMembrane GlycoproteinsImmunoglobulins

Autor:innen und Institutionen

  • Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Department of Oral Maxillofacial Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
  • Department of Diagnostic Pathology, Saitama Red Cross Hospital, Saitama, Japan.
  • Department of Hematology, Shinmatsudo Central General Hospital, Chiba, Japan.
  • Department of Hematology, Saitama Medical Center Saitama Medical University, Saitama, Japan.

Zitieren

APA

Sawada, K., Takahashi, T., Fukumura, Y., Onagi, H., Ashizawa, K., Yamashita, T., Yamamoto, W., Takayanagi, N., Adachi, A., Kashimura, M., Tabayashi, T., Tamaru, J. I., Higashi, M., & Momose, S. (2026). CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate. Journal of Clinical and Experimental Hematopathology, 66(1), 27-36. https://doi.org/10.3960/jslrt.25087

Vancouver

Sawada K, Takahashi T, Fukumura Y, Onagi H, Ashizawa K, Yamashita T, et al. CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate. Journal of Clinical and Experimental Hematopathology. 2026;66(1):27-36. doi:10.3960/jslrt.25087

BibTeX
@article{Sawada2026,
  author = {Sawada, Keisuke and Takahashi, Takumi and Fukumura, Yuki and Onagi, Hiroko and Ashizawa, Karin and Yamashita, Takahisa and Yamamoto, Wataru and Takayanagi, Natsuko and Adachi, Akiko and Kashimura, Makoto and Tabayashi, Takayuki and Tamaru, Jun-Ichi and Higashi, Morihiro and Momose, Shuji},
  title = {CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2026},
  volume = {66},
  number = {1},
  pages = {27--36},
  doi = {10.3960/jslrt.25087}
}
Kostenlos starten →